Alfa Wassermann S.p.a.

Patrizio Ferrari

Giuseppe Claudio Viscomi

Leone G Rotini

Maria Rosaria Pantaleo

Antonella Ferrieri

Lorenzo Morelli

Claudio Giuseppe Viscomi

Pietro Caramello

Leone Gabriele Rotini

The disclosure refers to biologically pure cultures of two strains ofnamed W11 and W11and deposited at the Belgian Coordinated Collections of Microorganisms (BCCM) that has registered them under the accession numbers LMG P-21586 and LMG P-21587. They are used as probiotics within preparations of pharmaceutical or alimentary products to help the gastrointestinal health and to prevent and treat the intestinal pathologies.

Bifidobacteria and preparations containing them

The use of therapeutically effective amounts of rifaxmin and of pharmaceutical compositions containing it in the treatment of the diarrhoeal symptomatology in case of cryptosporidiosis in patients suffering from severe forms of immunodepression, for instance patients suffering from AIDS or malignant neoplasias, or subjected to transplantations or treated with chemotherapeutic or immunosuppressive agents is the object of the present invention.

Use of rifaximin and of pharmaceutical compositions containing it in the

Growing community of inventors

Bologna, Italy

Patrizio Ferrari